Evaluation of Symptoms Improvement in NSCLC Patients With First-Line Therapy of EGFR Tyrosine Kinase Inhibitor

Clinical trial NCT01947868 · COMPLETED

Trial details

NCT number: NCT01947868
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Non-Small-Cell Lung Cancer

Start date: 2013-11-01
Primary completion: 2015-09-01
Enrollment: 346

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.